Featured in NEJM Journal Watch: Mounting Evidence Supports Colchicine for Pericarditis (FREE)
By the NEJM Journal Watch Editors
In a new … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 20, 2014 Category: Primary Care Source Type: news
ACC: Gout Drug Tames the Heart
WASHINGTON (MedPage Today) -- Colchicine may be as effective at reducing multiple recurrences of pericarditis as it is in treating acute episodes and first recurrences. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 30, 2014 Category: Cardiology Source Type: news
Colchicine reduces recurrence risk among patients with recurrent pericarditis
Read the full story on MD Consult:
Colchicine reduces recurrence risk among patients with recurrent pericarditis (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - March 29, 2014 Category: Journals (General) Source Type: news
How changes in the organized cell membrane network of heart muscle lead to heart failure
Colchicine, a drug that's used to treat gout, has the beneficial side effect of lowering the risk of heart attack in patients taking it. Conversely, taxol, a drug for treating cancer, has the opposite effect; raising the risk of heart failure.What both these drugs have in common is that they act on microtubules - a network of fibers inside heart cells that provide internal structural support. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 10, 2014 Category: Consumer Health News Tags: Heart Disease Source Type: news
Colchicine: Old drug with a new trick
Read the full story on MD Consult:
Colchicine: Old drug with a new trick (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - February 13, 2014 Category: Journals (General) Source Type: news
Fatal colchicine poisoning by accidental ingestion of colchicum persicum: A case report - Amrollahi-Sharifabadi M, Seghatoleslami A, Amrollahi-Sharifabadi M, Bayani F, Mirjalili M.
Colchicine poisoning can occur not only by taking dosage form but also by ingesting a plant containing colchicine. A 39-year-old man presented to the emergency room with nausea, vomiting, and diarrhea 9 hours after ingestion of wild garlic. Symptoms attrib... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 15, 2013 Category: Global & Universal Tags: Home and Consumer Product Safety Source Type: news
Colchicine Found Effective in Acute Pericarditis
Although colchicine has been shown to be beneficial in patients with recurrent pericarditis, which is thought to have a large inflammatory component related to an immune response, until now its efficacy in a first episode of acute pericarditis has been uncertain, as these episodes are thought to usually have a viral component that might benefit from an inflammatory response. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 12, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
The Shocking Truth About Medication Errors
Let’s say a physician writes a prescription for Colchicine and accidentally orders “10.0 mg,” when he should have ordered “1.0 mg.” That’s a tiny decimal error, a mistake even the best doctor could make. But it can be catastrophic for the patient. The higher dose could cause Colchicine poisoning, similar to arsenic poisoning: burning in the mouth and throat, excruciating abdominal pain. Internal organs would melt away and death would likely occur within 24 to 72 hours. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 3, 2013 Category: Pharmaceuticals Authors: Leah Binder Source Type: news
ESC: Colchicine Effective in Acute Pericarditis (CME/CE)
AMSTERDAM (MedPage Today) -- The anti-inflammatory agent colchicine -- used mostly in the treatment of gout -- appears to be effective for treating acute pericarditis and in preventing recurrences of the condition, researchers reported here. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 1, 2013 Category: Infectious Diseases Source Type: news
Colchicine Prevents Bare-Metal Stent Restenosis in DiabeticsColchicine Prevents Bare-Metal Stent Restenosis in Diabetics
Colchicine reduces neointimal hyperplasia and in-stent restenosis in diabetics who receive bare-metal coronary stents, Greek researchers say. Reuters Health Information (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 19, 2013 Category: Cardiology Tags: Cardiology News Source Type: news
CHMP recommends extension of canakinumab (Ilaris®) license to include treatment of gouty arthritis
Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) has recommended the adoption of a new indication for canakinumab (Ilaris®), as follows:
"Ilaris is indicated for the symptomatic treatment of adults patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate".
Detailed conditions for the use of thi...
Source: NeLM - News - January 21, 2013 Category: Drugs & Pharmacology Source Type: news
